To request more information about this product, please complete the form below.
CD2-CD58 Axis: Targets in Immune Synapse
Recent studies have highlighted the CD2-CD58 axis's relevance in cancer immunotherapy, suggesting its potential to enhance anti-tumor immunity and making it a promising target for therapeutic interventions. The CD2-CD58 axis is associated with the regulation of autoimmune diseases, immune evasion of tumors, antiviral responses, and immune rejection, and targeted therapies for this have been developed.
Sino Biological offers a wide range of recombinant CD2 and CD58 proteins and antibodies to support elucidating key interactions and pathways and shedding light on potential therapeutic strategies.